# Topical Cyclosporine and Disease Progression

> **NCT00567983** · PHASE4 · COMPLETED · sponsor: **Innovative Medical** · enrollment: 80 (estimated)

## Conditions studied

- Disease Progression
- Disease Severity
- Staining
- Schirmers
- OSDI

## Interventions

- **DRUG:** Restasis
- **DRUG:** Endura

## Key facts

- **NCT ID:** NCT00567983
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567983, "Topical Cyclosporine and Disease Progression". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00567983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*